Paradigm Biocapital Advisors LP

Insider Reports History

Entity
Company
Location
767 Third Avenue, 17 Th Floor, New York, NY
Signature
/s/ David Kim, as an authorized signatory of the Fund and the Adviser GP (for itself and on behalf of the Adviser)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paradigm Biocapital Advisors LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 6.59M $76.5M $11.60 Dec 6, 2023 By: Paradigm BioCapital International Fund Ltd.
Olema Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 4.72M $70.4M $14.92 Aug 1, 2024 By: Paradigm BioCapital International Fund Ltd.
Olema Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 1.31M $15.2M $11.60 Dec 6, 2023 By: One or more separately managed accounts
Olema Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 783K $11.7M $14.92 Aug 1, 2024 By: One or more separately managed accounts

Insider Reports Filed by Paradigm Biocapital Advisors LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OLMA Olema Pharmaceuticals, Inc. Aug 1, 2024 2 -$35.8M 4 Aug 5, 2024 10%+ Owner
OLMA Olema Pharmaceuticals, Inc. Dec 6, 2023 1 $1.16M 4 Dec 8, 2023 10%+ Owner
OLMA Olema Pharmaceuticals, Inc. Sep 12, 2023 0 $0 3 Sep 21, 2023 10%+ Owner